Market Cap
$2.1B
PEB
Pebblebrook Hotel Trust
$19.07 ▲ +1.38%
Prev close $18.81Market cap$2.1B
ConsensusSell
12-mo target$19.25 (+0.9%)
▲ Neutral
Analyst conviction 4/10
High Impact Filing (8/10)25 New Institutional Positions18 Institutional Exits Real Estate
Snapshot
The big-picture read on PEB right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Hold (37%)
Inst. Holders
50 funds
Inst. Value
$2.3B
Inst. Activity
25 buys / 18 sells
Insider Activity
$1.7M buy / $770.1K sell
Insider Net $
$971.3K
SEC Reports
8
Price chart 30d +7.6%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: PEB — 58.2% short (0.7M / 1.2M)
Short: 711,082 | Exempt: 0 | TRF Vol: 1,221,551 | Short Ratio: 58.2% | Off-exchange volume (dark poo
Aug 3, 2026 Insider
Fisher Thomas Charles sold 40,000 shares
Co-President, C Investmt Ofcr @ $19.25 ($770.1K)
Jun 30, 2026 Inst.
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP — DOUBLED
4,702,303 shares ($91.3M)
Jun 30, 2026 Inst.
Jun 15, 2026 SEC D. E. Shaw & — DOUBLED
2,728,760 shares ($53.0M)
Pebblebrook Hotel Trust CEO Jon E. Bortz purchased $1.74M of common stock over five consecutive trading days (June 8-12,
INSIDER-BUY — Impact 5/10
Pebblebrook Hotel Trust declared its Q2 2026 quarterly dividends: $0.01 per common share and regular preferred dividends
8-K — Impact 3/10
Pebblebrook Hotel Trust CEO Jon Bortz purchased $1.38M of stock over four consecutive trading days (June 8-11, 2026) at
INSIDER-BUY — Impact 5/10
Jun 12, 2026 Insider
BORTZ JON E bought 20,000 shares
Chairman and CEO @ $18.18 ($363.6K)
Analyst ratings buy % +270.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
37% rate it Buy or better · 19 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 28, 2026 | Raymond James | MAINTAIN | Outperform | 54% |
| Aug 27, 2026 | Barclays | MAINTAIN | Underweight | 54% |
| Aug 11, 2026 | Cantor Fitzgerald | MAINTAIN | Neutral | 49% |
| Jul 31, 2026 | Ladenburg Thalmann | MAINTAIN | Neutral | 45% |
| Jul 31, 2026 | Compass Point | UPGRADE | Neutral | 56% |
| Jul 30, 2026 | Stifel | MAINTAIN | Buy | 54% |
| Jul 28, 2026 | Evercore ISI Group | MAINTAIN | In-Line | 59% |
| Jul 23, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Jul 22, 2026 | Citigroup | MAINTAIN | Neutral | 55% |
| Jul 21, 2026 | Barclays | MAINTAIN | Underweight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 3 | 4 | 9 | 3 | 0 | 37% | |
| Aug 1, 2026 | 3 | 4 | 9 | 3 | 0 | 37% | |
| Jul 1, 2026 | 2 | 2 | 9 | 7 | 2 | 18% | |
| Jun 1, 2026 | 2 | 2 | 9 | 7 | 2 | 18% | |
| May 1, 2026 | 2 | 1 | 10 | 7 | 2 | 14% | |
| Apr 1, 2026 | 2 | 1 | 10 | 7 | 2 | 14% | |
| Mar 1, 2026 | 2 | 1 | 9 | 7 | 2 | 14% | |
| Feb 1, 2026 | 2 | 1 | 9 | 7 | 2 | 14% |
Price targets
Where 15 covering analysts think PEB trades over the next 12 months.
$19.25 +0.9% upside Hold
Current$19.07 Low$13.00 Median$19.50 High$22.00 15 analysts
$13.00$22.00
Analyst rating Hold· 2.8/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
8 SEC filing reports analyzed · 3 bullish, 0 bearish, 1 mixed, 4 neutral · avg impact 4.3/10.
BULLISHINSIDER-BUY5/10
Pebblebrook Hotel Trust CEO Jon E. Bortz purchased $1.74M of common stock over five consecutive trad
Jun 15, 2026
NEUTRAL8-K3/10
Pebblebrook Hotel Trust declared its Q2 2026 quarterly dividends: $0.01 per common share and regular
Jun 15, 2026
BULLISHINSIDER-BUY5/10
Pebblebrook Hotel Trust CEO Jon Bortz purchased $1.38M of stock over four consecutive trading days (
Jun 12, 2026
NEUTRAL8-K2/10
Pebblebrook Hotel Trust filed an 8-K under Item 7.01 solely to announce the date of its Q2 2026 earn
Jun 9, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: PEB — 58.2% short (0.7M / 1.2M)
Short: 711,082 | Exempt: 0 | TRF Vol: 1,221,551 | Short Ratio: 58.2% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: PEB — 60.6% short (0.4M / 0.6M)
Short: 371,690 | Exempt: 0 | TRF Vol: 613,712 | Short Ratio: 60.6% | Off-exchange volume (dark pool + OTC)
Sep 22, 2026
short_volume
Short Volume: PEB — 69.1% short (0.4M / 0.6M)
Short: 431,360 | Exempt: 0 | TRF Vol: 624,231 | Short Ratio: 69.1% | Off-exchange volume (dark pool + OTC)
Sep 16, 2026
short_volume
Short Volume: PEB — 68.5% short (0.4M / 0.6M)
Short: 436,321 | Exempt: 80 | TRF Vol: 636,606 | Short Ratio: 68.5% | Off-exchange volume (dark pool + OTC)
Sep 15, 2026
short_volume
Short Volume: PEB — 70.3% short (0.5M / 0.7M)
Short: 515,436 | Exempt: 832 | TRF Vol: 733,165 | Short Ratio: 70.3% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.02 | $-0.06–$0.02 | — | -300.0% | — | $0.4B | 2 |
| Next Q | $-0.24 | $-0.25–$-0.24 | — | -8.9% | — | $0.3B | 2 |
| Current FY | $-0.28 | $-0.30–$-0.26 | 37.0% | +12.5% | — | $1.5B | 2 |
| Next FY | $-0.27 | $-0.46–$-0.13 | 3.6% | +12.0% | 0↑ 1↓ | $1.5B | 3 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.020 | — |
| 7d ago | $-0.025 | +0.005 |
| 30d ago | $0.010 | -0.030 |
| 60d ago | $0.030 | -0.050 |
| 90d ago | $0.050 | -0.070 |
Institutional ownership
Which big funds own PEB (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $2.3B total value (120,467,020 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, UBS. Net buying activity: 25 institutions added/increased vs 18 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 19,908,675 | $386.4M | 16.5% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 11,291,661 | $219.2M | 9.4% | — |
| UBS Group AG | 7,549,549 | $146.5M | 6.3% | — |
| STATE STREET CORP | 6,453,363 | $125.3M | 5.4% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,927,685 | $95.6M | 4.1% | — |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 4,702,303 | $91.3M | 3.9% | DOUBLED +118.2% |
| EARNEST PARTNERS LLC | 4,538,986 | $88.1M | 3.8% | — |
| BANK OF AMERICA CORP /DE/ | 3,675,818 | $71.3M | 3.1% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 3,575,773 | $69.4M | 3.0% | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3,176,346 | $61.7M | 2.6% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 2,154,627 | 4,702,303 | +118.2% | $91.3M |
| D. E. Shaw & Co., Inc. | DOUBLED | 856,705 | 2,728,760 | +218.5% | $53.0M |
| JPMORGAN CHASE & CO | TRIM | 5,528,997 | 2,671,412 | -51.7% | $51.8M |
| Alyeska Investment Group, L.P. | TRIM | 6,101,996 | 2,451,933 | -59.8% | $47.6M |
| DUFF & PHELPS INVESTMENT MANAGEMENT CO | TRIM | 3,186,450 | 2,189,151 | -31.3% | $42.5M |
| MORGAN STANLEY | ADD | 1,443,372 | 1,830,351 | +26.8% | $35.5M |
| GOLDMAN SACHS GROUP INC | ADD | 1,138,975 | 1,803,249 | +58.3% | $35.0M |
| MILLENNIUM MANAGEMENT LLC | TRIM | 2,505,296 | 1,689,674 | -32.6% | $32.8M |
| JUPITER ASSET MANAGEMENT LTD | NEW | — | 1,372,368 | — | $26.6M |
| Nuveen, LLC | DOUBLED | 404,390 | 1,145,594 | +183.3% | $22.2M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
4 insiders, 10 transactions. Net $971.3K — $1.7M bought, $770.1K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Fisher Thomas Charles | Co-President, C Investmt Ofcr | SELL | 40,000 | $19.25 | $770.1K |
| Jun 12, 2026 | BORTZ JON E | Chairman and CEO | BUY | 20,000 | $18.18 | $363.6K |
| Jun 11, 2026 | BORTZ JON E | Chairman and CEO | BUY | 20,000 | $17.73 | $354.6K |
| Jun 10, 2026 | BORTZ JON E | Chairman and CEO | BUY | 20,000 | $17.23 | $344.6K |
| Jun 9, 2026 | BORTZ JON E | Chairman and CEO | BUY | 20,000 | $17.09 | $341.8K |
| Jun 8, 2026 | BORTZ JON E | Chairman and CEO | BUY | 20,000 | $16.84 | $336.8K |
| Mar 2, 2026 | Jones Nina P | Director | AWARD | 3,876 | — | — |
| Feb 5, 2026 | Fisher Thomas Charles | Co-President, C Investmt Ofcr | AWARD | 56,218 | — | — |
| Feb 5, 2026 | BORTZ JON E | Chairman and CEO | AWARD | 127,369 | — | — |
| Feb 5, 2026 | Martz Raymond D | Co-President,CFO,Treasurer,Sec | AWARD | 56,218 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for PEB.
Shares short
18,267,453
Settlement Sep 15, 2026
Change vs prior
+7.2%
Semi-monthly cycle
Days to cover
8.0
At avg daily volume
Of shares outstanding
≈16.2%
Estimate — not % of float
All PEB filing & press-release reports (8)
- INSIDER-BUY reportJun 15, 2026
- 8-K reportJun 15, 2026
- INSIDER-BUY reportJun 12, 2026
- 8-K reportJun 9, 2026
- 8-K reportJun 2, 2026
- 8-K reportApr 28, 2026
- DEFA14A reportApr 17, 2026
- 8-K reportFeb 25, 2026